Nexalin Technology (NXL) Competitors

Vivani Medical (NASDAQ:VANI) and Nexalin Technology (NASDAQ:NXL) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

Which has more risk & volatility, VANI or NXL?

Vivani Medical has a beta of 2.81, meaning that its share price is 181% more volatile than the S&P 500. Comparatively, Nexalin Technology has a beta of 4.67, meaning that its share price is 367% more volatile than the S&P 500.

Does the MarketBeat Community prefer VANI or NXL?

Vivani Medical received 5 more outperform votes than Nexalin Technology when rated by MarketBeat users. Likewise, 100.00% of users gave Vivani Medical an outperform vote while only 66.67% of users gave Nexalin Technology an outperform vote.

Company	Underperform	Outperform
Vivani Medical	Outperform Votes 7 100.00%	Underperform Votes No Votes
Nexalin Technology	Outperform Votes 2 66.67%	Underperform Votes 1 33.33%

Which has stronger valuation & earnings, VANI or NXL?

Nexalin Technology has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Nexalin Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivani Medical	N/A	N/A	-$25.65M	-$0.43	-2.63
Nexalin Technology	$131.07K	157.28	-$4.65M	-$0.83	-1.45

Does the media favor VANI or NXL?

In the previous week, Vivani Medical had 7 more articles in the media than Nexalin Technology. MarketBeat recorded 8 mentions for Vivani Medical and 1 mentions for Nexalin Technology. Vivani Medical's average media sentiment score of 0.45 beat Nexalin Technology's score of 0.00 indicating that Vivani Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vivani Medical	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nexalin Technology	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts recommend VANI or NXL?

Vivani Medical presently has a consensus target price of $4.00, indicating a potential upside of 253.98%. Nexalin Technology has a consensus target price of $5.00, indicating a potential upside of 316.67%. Given Nexalin Technology's higher probable upside, analysts clearly believe Nexalin Technology is more favorable than Vivani Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivani Medical	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Nexalin Technology	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do institutionals & insiders hold more shares of VANI or NXL?

6.8% of Vivani Medical shares are held by institutional investors. Comparatively, 0.6% of Nexalin Technology shares are held by institutional investors. 46.4% of Vivani Medical shares are held by company insiders. Comparatively, 24.0% of Nexalin Technology shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Is VANI or NXL more profitable?

Vivani Medical has a net margin of 0.00% compared to Nexalin Technology's net margin of -3,407.98%. Vivani Medical's return on equity of -102.42% beat Nexalin Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vivani Medical	N/A	-102.42%	-49.21%
Nexalin Technology	-3,407.98%	-187.59%	-167.21%

Summary

Vivani Medical beats Nexalin Technology on 10 of the 15 factors compared between the two stocks.